Market Overview:
The global combined oral contraceptive pill market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing awareness about contraception, rising prevalence of sexually transmitted infections (STIs), and growing demand for long-acting contraceptives. Based on type, the global combined oral contraceptive pill market is segmented into long-acting contraceptives and short-acting contraceptives. The long-acting contraceptives segment is expected to grow at a higher CAGR than the short-acting contraceptives segment during the forecast period from 2018 to 2030. This growth can be attributed to the increasing preference for long- acting contraceptives among women due to their high efficacy and convenience of use. Based on application, the global combined oral contraceptive pill market is divided into hospital pharmacies, drug stores, and online sale channels.
Product Definition:
The Combined Oral Contraceptive Pill (COCP) is a pill taken by mouth to prevent pregnancy. It contains two hormones, estrogen and progestin. It is important because it is one of the most effective methods of birth control available.
Long-acting Contraceptives:
Long-acting reversible Contraceptives (LARCs) are a class of birth control pills that contain an estrogen and a progesterone. The drug works by preventing the release of ovulation, thereby avoiding pregnancy. LARCs include subdermal implants (Nexplanon), intrauterine devices (IUD), and oral contraceptive drugs.
Short-acting Contraceptives:
Short-acting contraceptives are a group of birth control pills that contain an estrogen and a progesterone. They prevent pregnancy by acting as a contraceptive. The mechanism of action is based on the effect of the hormones present in the pill, which prevents implantation (the beginning of pregnancy) within the uterus.
The two most commonly used short-acting reversible oral contraceptives are norethindrone acetate.
Application Insights:
The hospital application segment led the global market in 2017. This is attributed to growing awareness about various health benefits of oral contraceptives and rising number of women aged 18-35 years seeking healthcare services at hospitals and clinics. In addition, a rise in the prevalence of reproductive disorders among women is expected to drive demand for combined oral contraceptives from the hospital segment over the forecast period.
The drug store application segment accounted for more than 30% share in 2017 owing to increasing availability of low-cost products coupled with high consumer expenditure on family planning activities due to changing lifestyles and rising concerns regarding population growth. Moreover, manufacturers are entering into agreements with retail chains offering discounts on purchases exceeding a certain amount thereby driving demand from this segment as well.
Regional Analysis:
Europe dominated the global market in 2017 owing to high product demand and awareness regarding oral contraceptives. Moreover, presence of well-established healthcare facilities in the region is expected to boost market growth during the forecast period. Asia Pacific is estimated to be fastest-growing regional market from 2018 to 2030 due to increasing women workforce, rising consumer awareness about contraceptive options, and improving economic condition of countries like India & China. In addition, government initiatives for distribution of free contraception are also anticipated fuel regional growth over the forecast period.
The Asia Pacific population includes two billion people who use some form of contraception; however only one out of every three women uses a modern method (oral contraceptive).
Growth Factors:
- Increasing awareness about contraception and family planning drives the growth of Combined Oral Contraceptive Pill market.
- Rising number of women in workforce leads to the increased demand for contraception, which in turn propels the growth of Combined Oral Contraceptive Pill market.
- Growing prevalence of sexually transmitted diseases (STDs) fuels the demand for contraceptives, thereby propelling the growth of Combined Oral Contraceptive Pill market.
- Technological advancements in contraceptive methods result in increased adoption of contraceptives, driving the growth of Combined Oral Contraceptive Pill market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Combined Oral Contraceptive Pill Market Research Report
By Type
Long-acting Contraceptives, Short-acting Contraceptives
By Application
Hospital, Drug Store, Online Sale
By Companies
Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, HRA Pharma, HLL Life Care, Syzygy Healthcare, V Care Pharma, Allergan, Lupin, Mankind, Piramal, Zhejiang Xianju Pharmaceutical Co
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Combined Oral Contraceptive Pill Market Report Segments:
The global Combined Oral Contraceptive Pill market is segmented on the basis of:
Types
Long-acting Contraceptives, Short-acting Contraceptives
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store, Online Sale
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Paladin Labs
- Foundation Consumer Healthcare
- Theramex (Teva)
- Pfizer
- Apotex
- HRA Pharma
- HLL Life Care
- Syzygy Healthcare
- V Care Pharma
- Allergan
- Lupin
- Mankind
- Piramal
- Zhejiang Xianju Pharmaceutical Co
Highlights of The Combined Oral Contraceptive Pill Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Long-acting Contraceptives
- Short-acting Contraceptives
- By Application:
- Hospital
- Drug Store
- Online Sale
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Combined Oral Contraceptive Pill Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Combined Oral Contraceptive Pill (COCP) is a pill taken by women to prevent pregnancy. It contains two types of hormones, estrogen and progestin. These hormones work together to prevent ovulation and the release of an egg from the ovary.
Some of the major companies in the combined oral contraceptive pill market are Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, HRA Pharma, HLL Life Care, Syzygy Healthcare, V Care Pharma, Allergan, Lupin, Mankind, Piramal, Zhejiang Xianju Pharmaceutical Co.
The combined oral contraceptive pill market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Combined Oral Contraceptive Pill Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Combined Oral Contraceptive Pill Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Combined Oral Contraceptive Pill Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Combined Oral Contraceptive Pill Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Combined Oral Contraceptive Pill Market Size & Forecast, 2018-2028 4.5.1 Combined Oral Contraceptive Pill Market Size and Y-o-Y Growth 4.5.2 Combined Oral Contraceptive Pill Market Absolute $ Opportunity
Chapter 5 Global Combined Oral Contraceptive Pill Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Combined Oral Contraceptive Pill Market Size Forecast by Type
5.2.1 Long-acting Contraceptives
5.2.2 Short-acting Contraceptives
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Combined Oral Contraceptive Pill Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Combined Oral Contraceptive Pill Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.2.3 Online Sale
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Combined Oral Contraceptive Pill Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Combined Oral Contraceptive Pill Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Combined Oral Contraceptive Pill Analysis and Forecast
9.1 Introduction
9.2 North America Combined Oral Contraceptive Pill Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Combined Oral Contraceptive Pill Market Size Forecast by Type
9.6.1 Long-acting Contraceptives
9.6.2 Short-acting Contraceptives
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Combined Oral Contraceptive Pill Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.10.3 Online Sale
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Combined Oral Contraceptive Pill Analysis and Forecast
10.1 Introduction
10.2 Europe Combined Oral Contraceptive Pill Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Combined Oral Contraceptive Pill Market Size Forecast by Type
10.6.1 Long-acting Contraceptives
10.6.2 Short-acting Contraceptives
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Combined Oral Contraceptive Pill Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.10.3 Online Sale
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Combined Oral Contraceptive Pill Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Combined Oral Contraceptive Pill Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Combined Oral Contraceptive Pill Market Size Forecast by Type
11.6.1 Long-acting Contraceptives
11.6.2 Short-acting Contraceptives
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Combined Oral Contraceptive Pill Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.10.3 Online Sale
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Combined Oral Contraceptive Pill Analysis and Forecast
12.1 Introduction
12.2 Latin America Combined Oral Contraceptive Pill Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Combined Oral Contraceptive Pill Market Size Forecast by Type
12.6.1 Long-acting Contraceptives
12.6.2 Short-acting Contraceptives
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Combined Oral Contraceptive Pill Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.10.3 Online Sale
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Combined Oral Contraceptive Pill Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Combined Oral Contraceptive Pill Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Combined Oral Contraceptive Pill Market Size Forecast by Type
13.6.1 Long-acting Contraceptives
13.6.2 Short-acting Contraceptives
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Combined Oral Contraceptive Pill Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.10.3 Online Sale
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Combined Oral Contraceptive Pill Market: Competitive Dashboard
14.2 Global Combined Oral Contraceptive Pill Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Paladin Labs
14.3.3 Foundation Consumer Healthcare
14.3.4 Theramex (Teva)
14.3.5 Pfizer
14.3.6 Apotex
14.3.7 HRA Pharma
14.3.8 HLL Life Care
14.3.9 Syzygy Healthcare
14.3.10 V Care Pharma
14.3.11 Allergan
14.3.12 Lupin
14.3.13 Mankind
14.3.14 Piramal
14.3.15 Zhejiang Xianju Pharmaceutical Co